|
|
IGF::OT::IGF CORE SUPPORT ACTIVITIES: SCIENTIFIC WRITING, TECHNICAL AND LOGISTICAL SUPPORT SERVICES
|
261201700004I
|
$1,200,000
|
$1,200,000
|
BIZZELL, ANTON
|
-
|
|
|
Exosomal Drug Delivery
|
5R44CA221487-02
|
$1,000,000
|
$1,000,000
|
SPENCER, WENDY
|
3P BIOTECHNOLOGIES, INC.
|
|
|
Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies
|
5R44CA162629-03
|
$833,374
|
$833,374
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
|
Oral formulation for novel inhibitor of Ras driven cancers
|
3R43CA217502-01A1S1
|
$2,000
|
$660
|
CANZONERI, JOSHUA
|
ADT PHARMACEUTICALS, LLC
|
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
$255,230
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-19
|
$417,500
|
$137,775
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
RCT of An Internet Cessation Program Plus Online Social Network for HIV + Smokers
|
5R01CA192954-05
|
$626,669
|
$626,669
|
SHUTER, JONATHAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Methylome characterization of bronchial epithelial projenitor cells
|
5R21CA209436-02
|
$180,130
|
$180,130
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-06
|
$346,525
|
$69,305
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
|
5R44CA189522-03
|
$692,728
|
$692,728
|
LEVENE, MICHAEL
|
APPLIKATE TECHNOLOGIES, LLC
|
|
|
Novel approaches to study immune responses to post translational modifications for cancer detection
|
5U01CA214201-03
|
$607,578
|
$303,789
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Improving pathologic nodal staging of resected lung cancer
|
2R01CA172253-06
|
$499,347
|
$499,347
|
OSAROGIAGBON, RAYMOND
|
BAPTIST MEMORIAL HOSPITAL - TIPTON
|
|
|
Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies
|
3U19CA203654-02S1
|
$147,830
|
$147,830
|
AMOS, CHRISTOPHER
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-05
|
$456,456
|
$456,456
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
$3,566
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
$7,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
$3,750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$96,094
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targeting aberrant promoter DNA methylation for anticancer therapy
|
1R21CA229727-01
|
$182,700
|
$182,700
|
SHEN, LANLAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Integration of Palliative Care for Cancer Patients on Phase I Trials
|
5R01CA177562-05
|
$1,384,347
|
$1,384,347
|
FERRELL, BETTY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
$203,455
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
$69,200
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
$3,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
|
1R01CA217841-01A1
|
$717,367
|
$717,367
|
SUN, VIRGINIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Unmet needs for specific subsets of EGFR mutated lung cancer
|
1R37CA218707-01A1
|
$409,171
|
$409,171
|
COSTA, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-04
|
$1,041,188
|
$520,594
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Overcoming resistance to tyrosine kinase inhibitors in lung cancer
|
5R01CA169259-06
|
$361,049
|
$361,049
|
KOBAYASHI, SUSUMU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
PathMAP NSCLC: A functional companion diagnostic test to predict optimal therapy for patients with non-small cell lung cancer.
|
5R44CA203068-03
|
$993,966
|
$993,966
|
BERTENSHAW, GREG
|
BIOMARKER STRATEGIES, LLC
|
|
|
Role of Insulin Receptor Substrates in Kras-driven lung cancer
|
5R01CA211944-02
|
$404,888
|
$404,888
|
KALAANY, NADA
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
Mechanisms of tumorigenesis in Brg1 mutant lung cancer
|
1R01CA216188-01A1
|
$683,713
|
$683,713
|
KIM, CARLA
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules
|
5R01CA210360-03
|
$621,526
|
$621,526
|
LENBURG, MARC
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
$626,379
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
|
1U2CCA233238-01
|
$6,692,860
|
$6,692,860
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
The Boston University-UCLA Lung Cancer Biomarker Development Lab
|
5U01CA214182-03
|
$518,499
|
$518,499
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S1
|
$3,249,644
|
$324,964
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
$100,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
$807,379
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Admin supplement - Chemical Approaches to Cell Signaling Enzymes
|
3R01CA074305-24S1
|
$73,513
|
$73,513
|
COLE, PHILIP
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Chemical Approaches to Cell Signaling Enzymes
|
5R01CA074305-24
|
$340,100
|
$340,100
|
COLE, PHILIP
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Molecular Pathogenesis of the Hamartoma Syndromes
|
2P01CA120964-11A1
|
$1,897,687
|
$341,584
|
KWIATKOWSKI, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
|
5R01CA203636-02
|
$567,838
|
$567,838
|
NISHINO, MIZUKI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Systemic RNA Delivery to Tumors
|
5R01CA200900-03
|
$545,070
|
$545,070
|
SHI, JINJUN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Center of Excellence for High Throughput Proteogenomic Characterization
|
5U24CA210986-03
|
$1,288,045
|
$425,055
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
|
Systematic identification of oncogenic KRAS synthetic lethal interactions
|
5U01CA199253-04
|
$807,776
|
$266,566
|
HAHN, WILLIAM
|
BROAD INSTITUTE, INC.
|
|
|
Lung Screening: Efficacy versus Effectiveness
|
1R01CA215240-01A1
|
$532,539
|
$532,539
|
GAREEN, ILANA
|
BROWN UNIVERSITY
|
|
|
Outcomes associated with significant incidental findings in lung cancer screening
|
5R01CA204222-02
|
$317,576
|
$317,576
|
GAREEN, ILANA
|
BROWN UNIVERSITY
|
|
|
Positive Psychotherapy for Smoking Cessation Enhanced with Text Messaging: A Randomized Controlled Trial
|
5R01CA201262-03
|
$546,238
|
$546,238
|
KAHLER, CHRISTOPHER
|
BROWN UNIVERSITY
|
|
|
Develop a rapid, efficient and low cost extracellular vesicles isolation method toward non-invasive non-small cell lung cancer molecular analysis
|
1R43CA228847-01A1
|
$300,000
|
$300,000
|
HE, HONGZHANG
|
CAPTIS DIAGNOSTICS
|
|
|
Identification and Targeting of Chemotherapy Refractory Small Cell Lung Cancer
|
1R21CA226322-01
|
$208,800
|
$208,800
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Overcoming resistance to first generation small molecule activators of PP2A.
|
1F30CA224977-01
|
$44,524
|
$44,524
|
LEONARD, DANIEL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Total relevant funding to Lung for this search: $350,113,126
|
